NCT04242940

Brief Summary

The purpose of this study is to assess listening effort during a speech-in-noise task in bone-anchored hearing systems (BAHS) users via pupillometry.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
25 days until next milestone

Study Start

First participant enrolled

February 21, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2022

Completed
3 years until next milestone

Results Posted

Study results publicly available

May 15, 2025

Completed
Last Updated

May 15, 2025

Status Verified

April 1, 2025

Enrollment Period

2.2 years

First QC Date

January 22, 2020

Results QC Date

March 13, 2025

Last Update Submit

April 28, 2025

Conditions

Keywords

Bone anchored hearing systemsBAHSListening effortPupillometryPonto 4

Outcome Measures

Primary Outcomes (1)

  • Overall Pupil Dilation

    Overall pupil dilation for OSN ON and OSN OFF at +4 dB SNR a third-order polynomial function was fit to the pupil dilation data, with the OSN setting as a fixed factor, as well as the interaction of OSN with each of the polynomial time terms. The formula used is the following: Pupil Dilation = (Linear + Quadratic + Cubic) X OSN setting + (1 + Linear + Quadratic + Cubic\| Subject); where the Linear, Quadratic, and Cubic are the orthogonal terms; X indicates the interaction with OSN setting, and the terms reported in the second parenthesis are the random factors. The random factors include the effect of listeners, and of each of the time terms, to account for the variability in the time course of dilation across listeners. Outcome measure is the percentage reduction(% change) in pupil dilation with OSN ON vs OSN OFF

    10 days

Secondary Outcomes (6)

  • Peak Pupil Dilation (PPD) for OSN ON and OSN OFF

    10 days

  • Speech Recognition Scores With OSN ON vs. OSN OFF Across SNRs

    10 days

  • Speech Spatial and Qualities of Hearing Scale (SSQ) Questionnaire Scores

    4 months

  • Preference Questionnaire Scores.

    4 months

  • Aided Sound Field Thresholds

    4 months

  • +1 more secondary outcomes

Other Outcomes (2)

  • Need for Recovery (NFR) Questionnaire Scores.

    4 months

  • Pupil Dilation After Field Trial.

    4 months

Study Arms (1)

Ponto 4 sound processor

EXPERIMENTAL

All patients will be fitted with a bone-anchored sound processor (Ponto 4), unilaterally or bilaterally.

Device: Fitting of Ponto 4

Interventions

Bone-anchored hearing systems (BAHS) use the body's natural ability to transfer sound through bone conduction. The sound processor picks up sound and converts it into vibrations that are transferred through the skull bone to the inner ear (cochlea). Thus, for patients with conductive or mixed hearing losses, patients with lasting hearing loss following a middle ear disease or malformations (such as microtia), the vibrations are bypassing the conductive problem in the ear canal or middle ear. The intervention in this study is audiologically fitting one/two bone-anchored sound processors (Ponto 4) to patients that are already implanted with abutments.

Ponto 4 sound processor

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Minimum 18 years and maximum 70 years old.
  • UK English mother tongue.
  • Bilateral conductive or mixed hearing loss.
  • Users fitted unilaterally or bilaterally on abutment.
  • Users are currently fitted with either Ponto 3, Ponto Plus or Ponto Pro (devices with a fitting range up to 45 dB HL).
  • Users with at least 6 months of daily experience with one Ponto sound processor.
  • BC thresholds of the implanted ear(s) better (lower) than or equal to 40 dB HL (average of 0.5, 1, 2 and 3 kHz) based on BC in-situ measurement at the first visit.
  • People currently employed/self-employed (since the Need for Recovery questionnaire refers to work-related fatigue).
  • Speech recognition scores better (higher) than or equal to 50% at +4 dB SNR with OSN OFF (as assessed via the first training list at Visit 1). This is to avoid including patients that are already "giving up" at +4 dB SNR.
  • Users entitled for a sound-processor upgrade (according to the investigator) will first be selected. If there are not enough users entitled for an upgrade, then patients fitted with Ponto between 7 and 12 months before visit 1 will be considered. If there are not enough users within 7-12 months, then patients fitted with Ponto between 13 and 18 months before visit 1 will be considered.

You may not qualify if:

  • Single-sided deafness (SSD)
  • Hearing aid or cochlear implant on the opposite ear.
  • Test persons with current eye diseases and/or history of eye surgery on both eyes.
  • If the patient takes medications that can impact the autonomic nervous system - and hence pupil dilation (e.g., drugs for Parkinson's disease, peptic ulcers, incontinence, motion sickness).
  • If the investigator or physician assesses that the patient is not fit for trial participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Audiology Department, Nuffield House, University Hospitals Birmingham

Birmingham, West Midlands, B15 2TH, United Kingdom

Location

MeSH Terms

Conditions

Hearing Loss, Bilateral

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Oticon Medical decided to terminate the study prematurely leading to a small sample size.

Results Point of Contact

Title
Manager of Clinical Affairs
Organization
Oticon Medical

Study Officials

  • William Brassington

    University Hospitals Birmingham, United Kingdom

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The participants are however blinded to the Ponto 4 setting (OpenSound Navigator ON/OFF in Ponto 4) activated for each list of sentences.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2020

First Posted

January 27, 2020

Study Start

February 21, 2020

Primary Completion

May 17, 2022

Study Completion

May 17, 2022

Last Updated

May 15, 2025

Results First Posted

May 15, 2025

Record last verified: 2025-04

Locations